Company: ORBS
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001641172-25-004802
Chunk: 1569

Company: Eightco Holdings Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 9C
Chunk 1569
---
Fadden’s health insurance for the period commencing on the Separation Date through December 31, 2024,
pursuant to applicable law, and approved but unpaid business expenses through the Separation Date within 30 days following the
Effective Date of the separation.

Pursuant
to the terms of the McFadden Severance Agreement, Mr. McFadden was to remain a director of the Company’s board from the
Separation Date through March 2024, at which time Mr. McFadden would resign from the Board. On March 17, 2024, the Board approved
the entry by the Company into the First Amendment to the McFadden Severance Agreement to amend Mr. McFadden’s end date of
service on the Board to March 17, 2024.

A
copy of the complete McFadden Severance Agreement is included as an exhibit to this Annual Report.

Brett
Vroman Employment Agreement

Pursuant
to the terms of the Vroman Employment Agreement, Mr. Vroman is employed as the Chief Financial Officer of the Company. Mr.
Vroman’s employment under the Vroman Employment Agreement was to last until September 27, 2024, unless earlier terminated
pursuant to the terms of the agreement.

Pursuant
to the terms of Mr. Vroman’s employment agreement, Mr. Vroman was to receive, subject to approval by the Board, an annual grant of
180,000 restricted stock units convertible into shares of the Company’s common stock, which shall be immediately vested and subject
to the terms and conditions of the Company’s 2022 Long-Term Incentive Plan. This reflects an increase from the 135,000 shares provided
to Mr. Vroman under the March Vroman Agreement. Mr. Vroman will be entitled to a base salary payable at the annualized rate of $292,000
per year (the “Vroman Base Salary”), which reflects an increase from the $250,000 provided to Mr. Vroman under the March
Vroman Agreement. Mr. Vroman is eligible for an annual cash bonus opportunity equal to 100% of the Vroman Base Salary (the “Vroman
Bonus”) based on the achievement of performance goals as determined by the Company’s audit committee and the Board. The Vroman
Bonus reflects a decrease on a percentage basis from the maximum 150% of base salary provided for in the March Vroman Agreement.

In
addition, Mr